{"name":"Universitas Sebelas Maret","slug":"universitas-sebelas-maret","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Hyperbaric Lidocaine 5%","genericName":"Hyperbaric Lidocaine 5%","slug":"hyperbaric-lidocaine-5","indication":"Other","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Oral lumbrokinase DLBS1033","genericName":"Oral lumbrokinase DLBS1033","slug":"oral-lumbrokinase-dlbs1033","indication":"Thromboembolism and blood stasis-related conditions","status":"marketed"}]}],"pipeline":[{"name":"Hyperbaric Lidocaine 5%","genericName":"Hyperbaric Lidocaine 5%","slug":"hyperbaric-lidocaine-5","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Oral lumbrokinase DLBS1033","genericName":"Oral lumbrokinase DLBS1033","slug":"oral-lumbrokinase-dlbs1033","phase":"marketed","mechanism":"Lumbrokinase is a fibrinolytic enzyme derived from earthworm that breaks down fibrin clots and improves blood flow.","indications":["Thromboembolism and blood stasis-related conditions","Diabetic angiopathy","Cerebrovascular disorders"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPSmJRdHFiNkpha0wydUdWclN0OWhQaWJON2lDcTFQQ29QcGUydUZuOGgweUFIQjk0SWgyaGZnVng0SXV1bFRBa0JVQ25OOW5VMUN4RVpjREFyLUF4a29UWVo4aHl2S3gzd3Z1UkhRbU11dmZnV2FUZ0pNNU9GZWNsWTZBTHh0ek0tTUdVdmNaajNzTDROa05CbA?oc=5","date":"2024-09-19","type":"pipeline","source":"Universitas Sebelas Maret","summary":"Faculty of Medicine UNS Signs Cooperation Agreement with PT Sido Muncul - Universitas Sebelas Maret","headline":"Faculty of Medicine UNS Signs Cooperation Agreement with PT Sido Muncul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNNWtaa1VaZHIyZ2h0TEdhSzhCNVhiR3hQOEw5UVJMeDI2WTFFTEJPeWpRMGwwektvUXR3ME54Ml9KREJNVnZBX1JZcEdBR2hUTS0wNmRHRlBWTzlCR3NyUW1VR2hLODVueWphVWZZc0EtenluclFkbDN5VG9TQS1YNFZNNnlxckY4ZWxvaTFiVl8zVzh0UFlwSVc2elJNX2E1YVBj?oc=5","date":"2023-07-20","type":"pipeline","source":"Universitas Sebelas Maret","summary":"PKM D3 Pharmacy UNS Develops Non-Alcohol Hand Sanitizer Gel from Citronella Oil - Universitas Sebelas Maret","headline":"PKM D3 Pharmacy UNS Develops Non-Alcohol Hand Sanitizer Gel from Citronella Oil","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNbGgyVTkxZ2RJaklUMDFFUi1FTVV5djR3V3ByeElHNXVjRGpFUnR3S1p5M2RZOGdpU1F0VzN6Z2Flbjd5WW5pWW5hRzhGTzBfTDVpNHMxWVR2VnUwM3J3Q0htcXVVMXBJc19sM1Nfa01MOVJaZU1ISy1fcFRqRXpMZUd5emM1emM1c2RZMVNvTDRQenVEc20xOWw2UVQzbC1vMEpaTkRnTGZDZw?oc=5","date":"2021-07-09","type":"pipeline","source":"Universitas Sebelas Maret","summary":"Diploma Program in Pharmacy UNS Assists Independent Hand Sanitizer Production School - Universitas Sebelas Maret","headline":"Diploma Program in Pharmacy UNS Assists Independent Hand Sanitizer Production School","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOOUpJSmpBNGd2T25CdHM1MEpMTjlzSnVrUUlEbnVobC1fUXFoalh4a0NodjFmcThSQlYxMU1IRElFZVZFUFY4YUFvZHlxZVFyV3FQQXgtWWlQMm5yZlhjWmFTQkRSZEhISi1VOTBIbHZEOGphUktNSFJCTldQa2NONVhkOVZ0d1dQSVNuLS16MXJ4Z3EwNHFV?oc=5","date":"2020-09-07","type":"pipeline","source":"Universitas Sebelas Maret","summary":"UNS Pharmacy Research Group Establish Pharmacy Corner in Tamcer Jebres - Universitas Sebelas Maret","headline":"UNS Pharmacy Research Group Establish Pharmacy Corner in Tamcer Jebres","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}